Breaking News, Collaborations & Alliances

Moderna, Life Edit Partner on In Vivo Gene Therapies

Collaboration combines Moderna's mRNA platform with Life Edit's gene editing technologies, including base editing capabilities.

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., and ElevateBio company focused on next-generation gene editing technologies and therapeutics, entered a strategic research and development collaboration to discover and develop in vivo mRNA gene editing therapies. The partnership will combine Life Edit’s suite of gene editing technologies, including base editing, with Moderna’s mRNA platform to advance ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters